Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome FunctionShengyan Xiang(Moffitt Cancer Center), Mark G. Alexandrow(Moffitt Cancer Center)Molecular Cancer TherapeuticsJuly 10, 202410.1158/1535-7163.mct-23-0904Cited by 6SaveCiteExport RISWatch citationsRelated PapersCdc45 Limits Replicon Usage from a Low Density of preRCs in Mammalian Cells|PLoS ONE|2011|97Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function|Research Square|2023|3